Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (3.912)

1

Ramucirumab as a second line therapy for advanced HCC : a significant achievement or a wasted opportunity for personalised therapy?

enthalten in: Investigational new drugs | 2019

von Roviello, G. | Sohbani, N. | Petrioli, R. | +1

2

A New Era in the Treatment of Thyroid Eye Disease

enthalten in: American journal of ophthalmology | 2019

von Patel, A. | Yang, H. | Douglas, R.

3

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY) : a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Oncology | 2019

von Nakagawa, K. | Garon, E. | Seto, T. | +118

CommentIn: Lancet Oncol. 2019 Dec;20(12):1617-1618. - PMID 31591061

4

Effect of Early Adverse Events on Survival Outcomes of Patients with Metastatic Colorectal Cancer Treated with Ramucirumab

enthalten in: Targeted oncology | 2019

von Lim, H. | Hopkins, A. | Rowland, A. | +3

5

Photoimmunotherapy targeting biliary-pancreatic cancer with humanized anti-TROP2 antibody

enthalten in: Cancer medicine | 2019

von Nishimura, T. | Mitsunaga, M. | Sawada, R. | +6

6

Efficacy of late line pertuzumab with trastuzumab and chemotherapy in HER2-positive metastatic breast cancer : An Australian case series

enthalten in: Asia-Pacific journal of clinical oncology | 2019

von Bergin, A. | Luen, S. | Savas, P. | +8

7

fam-] trastuzumab deruxtecan, antitumor activity is dependent on HER2 expression level rather than on HER2 amplification

enthalten in: International journal of cancer | 2019

von Takegawa, N. | Tsurutani, J. | Kawakami, H. | +8

8

Are neutralising anti-VEGF or VEGFR2 antibodies necessary in the treatment of EGFR-mutated non-small-cell lung cancer?

enthalten in: The Lancet. Oncology | 2019

von Rosell, R. | Pedraz-Valdunciel, C.

CommentOn: Lancet Oncol. 2019 Dec;20(12):1655-1669. - PMID 31591063

9

The comparative efficacy and risk of harms of the intravenous and subcutaneous formulations of trastuzumab in patients with HER2-positive breast cancer : a rapid review

enthalten in: Systematic reviews | 2019

von Van den Nest, M. | Glechner, A. | Gold, M. | +1

10

Patritumab or placebo, with cetuximab plus platinum therapy in recurrent or metastatic squamous cell carcinoma of the head and neck : A randomised phase II study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2019

von Forster, M. | Dillon, M. | Kocsis, J. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[392]